289 related articles for article (PubMed ID: 21362193)
1. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.
Heininger A; Haeberle H; Fischer I; Beck R; Riessen R; Rohde F; Meisner C; Jahn G; Koenigsrainer A; Unertl K; Hamprecht K
Crit Care; 2011; 15(2):R77. PubMed ID: 21362193
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
Frantzeskaki FG; Karampi ES; Kottaridi C; Alepaki M; Routsi C; Tzanela M; Vassiliadi DA; Douka E; Tsaousi S; Gennimata V; Ilias I; Nikitas N; Armaganidis A; Karakitsos P; Papaevangelou V; Dimopoulou I
J Crit Care; 2015 Apr; 30(2):276-81. PubMed ID: 25457114
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
Limaye AP; Stapleton RD; Peng L; Gunn SR; Kimball LE; Hyzy R; Exline MC; Files DC; Morris PE; Frankel SK; Mikkelsen ME; Hite D; Enfield KB; Steingrub J; O'Brien J; Parsons PE; Cuschieri J; Wunderink RG; Hotchkin DL; Chen YQ; Rubenfeld GD; Boeckh M
JAMA; 2017 Aug; 318(8):731-740. PubMed ID: 28829877
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus reactivation in critically ill immunocompetent patients.
Limaye AP; Kirby KA; Rubenfeld GD; Leisenring WM; Bulger EM; Neff MJ; Gibran NS; Huang ML; Santo Hayes TK; Corey L; Boeckh M
JAMA; 2008 Jul; 300(4):413-22. PubMed ID: 18647984
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study.
Zhang Z; Liu X; Sang L; Chen S; Wu Z; Zhang J; Sun Y; Huang Y; Xu Y; He W; Li Y; Liu X
BMC Infect Dis; 2021 Sep; 21(1):1026. PubMed ID: 34592936
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of multiple viruses in patients with sepsis.
Walton AH; Muenzer JT; Rasche D; Boomer JS; Sato B; Brownstein BH; Pachot A; Brooks TL; Deych E; Shannon WD; Green JM; Storch GA; Hotchkiss RS
PLoS One; 2014; 9(2):e98819. PubMed ID: 24919177
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J
Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489
[TBL] [Abstract][Full Text] [Related]
8. Association between Pulmonary Aspergillosis and
Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus reactivation in critically ill immunocompetent patients.
Libert N; Bigaillon C; Chargari C; Bensalah M; Muller V; Merat S; de Rudnicki S
Biomed J; 2015; 38(1):70-6. PubMed ID: 25179711
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality.
Gatto I; Biagioni E; Coloretti I; Farinelli C; Avoni C; Caciagli V; Busani S; Sarti M; Pecorari M; Gennari W; Guaraldi G; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Cossarizza A; Girardis M;
Intensive Care Med; 2022 Jun; 48(6):706-713. PubMed ID: 35583676
[TBL] [Abstract][Full Text] [Related]
11. Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
Kalil AC; Florescu DF
Crit Care; 2011; 15(2):138. PubMed ID: 21457496
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
Tassaneeyasin T; Sungkanuparph S; Srichatrapimuk S; Charoensri A; Thammavaranucupt K; Jayanama K; Kirdlarp S
PLoS One; 2024; 19(5):e0303995. PubMed ID: 38771836
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2020 Aug; 99(8):1883-1893. PubMed ID: 32572523
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus Reactivation in Patients with Sepsis in an Intensive Care Unit in Portugal.
Paixão P; Ramos P; Piedade C; Casado A; Chasqueira M
Acta Med Port; 2020 Sep; 33(9):576-582. PubMed ID: 32498761
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO.
Hraiech S; Bonnardel E; Guervilly C; Fabre C; Loundou A; Forel JM; Adda M; Parzy G; Cavaille G; Coiffard B; Roch A; Papazian L
Ann Intensive Care; 2019 Dec; 9(1):142. PubMed ID: 31872319
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY;
Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis.
Li X; Huang Y; Xu Z; Zhang R; Liu X; Li Y; Mao P
BMC Infect Dis; 2018 Jun; 18(1):289. PubMed ID: 29954328
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
Cowley NJ; Owen A; Shiels SC; Millar J; Woolley R; Ives N; Osman H; Moss P; Bion JF
JAMA Intern Med; 2017 Jun; 177(6):774-783. PubMed ID: 28437539
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
